91 – 100 of 145
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
(
- Contribution to journal › Article
- 2012
-
Mark
Computerised assistance for warfarin dosage - Effects on treatment quality
(
- Contribution to journal › Article
-
Mark
Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
(
- Contribution to journal › Article
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
(
- Contribution to journal › Article
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
(
- Contribution to journal › Article
-
Mark
Ateroskleros och trombogenes
2012)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Ateroskleros och trombogenes
2012) p.21-27(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2011
-
Mark
Risk factors for hemorrhage during local intra-arterial thrombolysis for lower limb ischaemia
(
- Contribution to journal › Article
-
Mark
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
(
- Contribution to journal › Article